| 2024-03-28 11:36 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.83 | News Release200 | Ceapro, Aeterna merger receives court approval |
| 2024-03-27 12:39 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.77 | News Release200 | Aeterna Zentaris loses $16.6-million (U.S.) in 2023 |
| 2024-03-27 08:22 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.77 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2024-03-27 08:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.77 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-03-27 08:14 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.77 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-03-12 14:33 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.72 | News Release200 | Ceapro, Aeterna holders OK merger at March 3 meeting |
| 2024-02-26 12:40 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.57 | News Release200 | Aeterna, Ceapro receive proxy support for merger |
| 2024-02-15 18:01 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.41 | News Release200 | Aeterna urges shareholders to approve Ceapro merger |
| 2023-12-14 09:27 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.90 | News Release200 | Aeterna Zentaris, Ceapro sign definitive merger deal |
| 2023-12-14 08:11 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.90 | Resume Trading385 | Aeterna Zentaris resuming at the open |
| 2023-12-14 07:58 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.90 | Halt Trading170 | Aeterna Zentaris halted at the open |
| 2023-11-09 13:55 | CC:AEZS | Aeterna Zentaris Inc (4) | | News Release200 | Aeterna Zentaris loses $4.1-million (U.S.) in Q3 |
| 2023-11-09 10:10 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.14 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-11-09 10:07 | CC:AEZS | Aeterna Zentaris Inc (4) | 2.14 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-08-09 14:26 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.90 | News Release200 | Aeterna Zentaris loses $2.5-million (U.S.) in Q2 2023 |
| 2023-08-09 08:19 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.90 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-13 12:30 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.77 | News Release200 | Aeterna sees positive preclinical data for AIM proteins |
| 2023-06-14 16:39 | CC:AEZS | Aeterna Zentaris Inc (4) | | News Release200 | Aeterna Zentaris shareholders approve AGM resolutions |
| 2023-05-09 19:00 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | News Release200 | Aeterna loses $4.3-million (U.S.) in Q1 |
| 2023-05-09 17:08 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-05-09 17:08 | CC:AEZS | Aeterna Zentaris Inc (4) | 3.91 | SEDAR MD & A815 | SEDAR MD & A |